Login to Your Account

Which Biotech Programs Will Survive?

Going Global: Takeda Paying $13.7B Cash for Nycomed

By Cormac Sheridan

Friday, May 20, 2011
Takeda Pharmaceutical Co. Ltd. is beefing up its presence in emerging markets and in Europe by paying $13.7 billion in cash for Nycomed GmbH, a privately held mid-sized pharma company.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription